Hepatitis Network for Education and Testing (HepNET)
Through this CDC cooperative agreement, NASTAD (National Alliance of State and Territorial AIDS Directors) and their partners National Viral Hepatitis Roundtable (NVHR) and National Association of County and City Health Officials (NACCHO) are focusing on improving the health of people at risk of overdose. Together they are growing a network of Health Departments, Community-Based Organizations, healthcare providers, and other partners of diverse geographic representation that serve people at risk of overdose. NASTAD and its partners will provide technical assistance and training to network members with a focus on hepatitis B and hepatitis C testing and linkage to care. Additionally, NASTAD will promote CDC’s hepatitis B and hepatitis C campaign resources.
Join the Network
To join our network, please complete the form here. If you have any issues with this form, or for any HepNET questions, please reach out to Phillip Rideoutt, II via prideoutt@nastad.org
The HepNET LLE Webinar Series Returns January 7, 2026!
Register today for the HepNET Leading with Lived Experience (LLE) webinar series that takes place the First Wednesday of Every Month at 3 PM ET.
HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLE Consultants to hold in-depth conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life.
To register, click Here.
Mission
HepNET is committed to identifying and addressing the unmet needs of people at risk of overdose by improving access to viral hepatitis education, prevention, testing, linkage to care, and treatment, guided and informed by the voices, perspectives, insights, and lived experiences.
Vision
Improve health outcomes for people at risk of overdose by decreasing the burden of viral hepatitis and other preventable harms.
NASTAD Contact Information
For any other questions, comments, or concerns, please contact NASTAD at hepatitis@nastad.org.